NYSE ARCA | ETF
In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the index), the fund employs a sampling strategy.
It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index.
The index represents the pharmaceuticals segment of the S&P Total Market Index (S&P TMI).
Top 20 Holdings
Asset | Name | Sector | Industry | Weight |
---|---|---|---|---|
CORT | Corcept Therapeutics Incorporated | Healthcare | Biotechnology | 4.93% |
LBPH | Longboard Pharmaceuticals Inc | Healthcare | Biotechnology | 4.26% |
BMY | Bristol-Myers Squibb Company | Healthcare | Drug Manufacturers - General | 4.12% |
VTRS | Viatris Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.98% |
ITCI | Intracellular Th | Healthcare | Drug Manufacturers - Specialty & Generic | 3.90% |
JAZZ | Jazz Pharmaceuticals PLC | Healthcare | Biotechnology | 3.86% |
CBAY | Cymabay Therapeu | Healthcare | Biotechnology | 3.73% |
AXSM | Axsome Therapeutics Inc | Healthcare | Biotechnology | 3.52% |
CTLT | Catalent Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.52% |
PRGO | Perrigo Company PLC | Healthcare | Drug Manufacturers - Specialty & Generic | 3.46% |
JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 3.34% |
RPRX | Royalty Pharma Plc | Healthcare | Biotechnology | 3.32% |
ELAN | Elanco Animal Health | Healthcare | Drug Manufacturers - Specialty & Generic | 3.32% |
EWTX | Edgewise Therapeutics Inc | Healthcare | Biotechnology | 3.32% |
ZTS | Zoetis Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.29% |
PFE | Pfizer Inc | Healthcare | Drug Manufacturers - General | 3.03% |
MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 2.97% |
SAVA | Cassava Sciences Inc | Healthcare | Biotechnology | 2.84% |
LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 2.81% |
TARS | Tarsus Pharmaceuticals Inc | Healthcare | Biotechnology | 2.78% |